Trade Summary

6 days ago, Wong Hing C, serving as Chief Executive Officer at HCW Biologics Inc. (HCWB), purchased 113,879 shares at $1.41 per share, for a total transaction value of $160,000.00. Following this transaction, Wong Hing C now holds 615,790 shares of HCWB.

This purchase represents a 22.69% increase in Wong Hing C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 7:26 PM ET, 5 days after the trade was made.

HCW Biologics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.